Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kerwin, R. W.
Busatto, G. F.
Pilowsky, L. S.
Ell, P. J.
Costa, D. C.
and
Verhoeff, N. P. L. G.
1993.
Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone.
British Journal of Psychiatry,
Vol. 163,
Issue. 6,
p.
833.
Busatto, G. F.
Pilowsky, L. S.
Kerwin, R. W.
Costa, D. C.
Ell, P. J.
and
Verhoeff, N. P. L. G.
1995.
Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride — an123I-IBZM single photon emission tomography (SPET) study.
Psychopharmacology,
Vol. 117,
Issue. 1,
p.
55.
Meltzer, H. Y.
1995.
Psychotic Continuum.
p.
31.
Schl�sser, R.
and
Schlegel, S.
1995.
D2-receptor imaging with [123I]IBZM and Single Photon Emission Tomography in psychiatry: a survey of current status.
Journal of Neural Transmission,
Vol. 99,
Issue. 1-3,
p.
173.
Goldberg, Terry E.
Berman, Karen F.
and
Weinberger, Daniel R.
1995.
Neuropsychology and neurophysiology of schizophrenia.
Current Opinion in Psychiatry,
Vol. 8,
Issue. 1,
p.
34.
Schlegel, S.
1995.
Single-Photon-Emissions-Computertomographie (SPECT) des Gehirns.
p.
72.
Malizia, A.
Forse, G.
Haida, A.
Gunn, R.
Melichar, J.
Poole, K.
Bateman, D.
Fahy, D.
Schnorr, L.
Brown, D.
Rhodes, C.
Nutt, D.J.
and
Jones, T.
1995.
A new human (psycho)pharmacology tool: the multiple organs coincidences counter (MOCC).
Journal of Psychopharmacology,
Vol. 9,
Issue. 4,
p.
294.
Kerwin, Robert W.
and
Pilowsky, Lyn S.
1995.
Traditional receptor theory and its application to neuroreceptor measurements in functional imaging.
European Journal of Nuclear Medicine,
Vol. 22,
Issue. 7,
p.
699.
Koreen, Amy R.
Sheitman, Brian
and
Lieberman, Jeffrey
1996.
Antipsychotics.
Vol. 120,
Issue. ,
p.
389.
Sharma, Tonmoy
and
Kerwin, Robert
1996.
Biological Determinants of Difficult to Treat Patients with Schizophrenia.
British Journal of Psychiatry,
Vol. 169,
Issue. S31,
p.
5.
Kuperberg, GR
and
Murray, R
1996.
ADVANCES IN THE TREATMENT OF SCHIZOPHRENIA.
International Journal of Clinical Practice,
Vol. 50,
Issue. 6,
p.
315.
Pilowsky, L. S.
Busatto, G. F.
Taylor, M.
Sharma, T.
Sigmundsson, T.
Costa, D. C.
Ell, P. J.
and
Nohria, V.
1996.
Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine — a123 IBZM single photon emission tomography (SPET) study.
Psychopharmacology,
Vol. 124,
Issue. 1-2,
p.
148.
1996.
ORAL COMMUNICATIONS.
British Journal of Pharmacology,
Vol. 117,
Issue. S1,
Kerwin, Robert W.
and
Collier, David
1996.
The dopamine D4 receptor in schizophrenia: an update.
Psychological Medicine,
Vol. 26,
Issue. 2,
p.
221.
Kerwin, Robert W.
1996.
An essay on the use of new antipsychotics.
Psychiatric Bulletin,
Vol. 20,
Issue. 1,
p.
23.
Schlegel, S.
Schlößer, R.
Nickel, O.
and
Bockisch, A.
1996.
Aktuelle Perspektiven der Biologischen Psychiatrie.
p.
732.
Mulcrone, J.
and
Kerwin, R.W.
1996.
No difference in the expression of the D4 gene in post-mortem frontal cortex from controls and schizophrenics.
Neuroscience Letters,
Vol. 219,
Issue. 3,
p.
163.
Busatto, G.F.
and
Kerwin, R.W.
1997.
Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia.
Journal of Psychopharmacology,
Vol. 11,
Issue. 1,
p.
3.
Acton, Paul D.
Pilowsky, Lyn S.
Costa, Durval C.
and
Ell, Peter J.
1997.
Multivariate cluster analysis of dynamic iodine-123 iodobenzamide SPET dopamine D2 receptor images in schizophrenia.
European Journal of Nuclear Medicine,
Vol. 24,
Issue. 2,
p.
111.
Pilowsky, L. S.
1998.
Clinical Nuclear Medicine.
p.
277.